Familial Risk-Colorectal Cancer: ESMO Clinical Practice Guidelines | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
guides & guidelines

Familial Risk-Colorectal Cancer: ESMO Clinical Practice Guidelines

key information

source: Annals of oncology

year: 2013

authors: Balmaña J, Balaguer F, Cervantes A, Arnold D, ESMO Guidelines Working Group

summary/abstract:

Lynch syndrome is the most common hereditary colorectal cancer (CRC) syndrome and it accounts for ∼1%–3% of all CRC burden. The syndrome is transmitted with an autosomal-dominant pattern, and it is associated with mutations in the mismatch repair (MMR) genes, MLH1, MSH2, MSH6 and PMS2. These alterations lead to tumour DNA microsatellite instability (MSI) and foster inactivating mutations in tumour suppressors containing microsatellites in the coding regions (i.e. TGFBR2 and BAX) . Mutations in the MMR genes may lead to a loss of expression of the corresponding protein and be detected by immunohistochemistry techniques (IHCs).

organization: Universitat Autònoma de Barcelona

DOI: 10.1093/annonc/mdt209

read more full text source

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close